Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study.
Lancet Reg Health Southeast Asia. 2023 Jan 24;12:100141. doi: 10.1016/j.lansea.2023.100141. Online ahead of print.
Lancet Reg Health Southeast Asia. 2023.
PMID: 36712811
Free PMC article.
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
Chaudhary A, Madhavan R, Babji S, Raju R, Syed C, Kumar A, Saravanan P, Sharon Nikitha O, Leander Xavier JV, David Chelladurai JS, Deborah AA, George A, Kang G, Rose W.
Chaudhary A, et al. Among authors: leander xavier jv.
Vaccine. 2023 Jul 25;41(33):4808-4822. doi: 10.1016/j.vaccine.2023.06.059. Epub 2023 Jun 23.
Vaccine. 2023.
PMID: 37357073
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.